Korro Bio (KRRO) Interest Expenses (2018 - 2026)
Korro Bio (KRRO) posted Interest Expenses of $22.7 million for Q1 2026, up 22615.0% on a QoQ basis from $100000.0 in Q4 2025, and up 11257.5% year-over-year from N/an in Q1 2025.
Korro Bio (KRRO) Interest Expenses (2018 - 2026) Analysis & Trends
Korro Bio's Interest Expenses history runs 9 years deep, the most recent figure standing at $22.7 million for Q1 2026.
- Quarterly Interest Expenses rose 11257.5% year-over-year to $22.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.7 million (up 3685.83% YoY) and the FY2025 annual result came in at $202.3 million, up 849.19% from the prior year.
- Interest Expenses was $22.7 million for Q1 2026 at Korro Bio, up from $100000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $71.9 million in Q3 2024 and bottomed at -$449000.0 in Q4 2022.
- A 5-year average of $14.5 million and a median of $284000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 346.7% — and 2024, when it jumped 2395466.67%.
- Korro Bio's Interest Expenses stood at -$449000.0 in 2022, then surged by 122.27% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then soared by 22615.0% to $22.7 million in 2026.
- Business Quant data shows KRRO's Interest Expenses at $22.7 million in Q1 2026, $100000.0 in Q4 2025, and $42.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.17 Bn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 22.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.72 Mn |
| Mar 31, 2026 | 22.72 Mn |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 42.06 Mn |
| Sep 30, 2025 | 42.06 Mn |
| Jun 30, 2025 | 36.71 Mn |
| Jun 30, 2025 | 36.71 Mn |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 71.87 Mn |
| Sep 30, 2024 | 71.87 Mn |
| Jun 30, 2024 | 69.68 Mn |
| Jun 30, 2024 | 69.68 Mn |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |